Go offline with the Player FM app!
🧬 Targeting Aldosterone: A New Shot at Hypertension 🎯💥
Manage episode 492751435 series 2740117
🚨 New breakthrough in hypertension care!
💊 The Launch-HTN trial shows lorundrostat — a selective aldosterone synthase inhibitor — significantly lowers systolic BP in patients with uncontrolled or treatment-resistant hypertension.
📉 −16.9 mmHg vs −7.9 mmHg with placebo (P < .001)
🧪 Safe, well-tolerated, and effective across subgroups.
A potential game-changer in aldosterone-targeted therapy! 🔄💥 #Hypertension #Cardiology #ClinicalTrials #PrecisionMedicine
553 episodes
Manage episode 492751435 series 2740117
🚨 New breakthrough in hypertension care!
💊 The Launch-HTN trial shows lorundrostat — a selective aldosterone synthase inhibitor — significantly lowers systolic BP in patients with uncontrolled or treatment-resistant hypertension.
📉 −16.9 mmHg vs −7.9 mmHg with placebo (P < .001)
🧪 Safe, well-tolerated, and effective across subgroups.
A potential game-changer in aldosterone-targeted therapy! 🔄💥 #Hypertension #Cardiology #ClinicalTrials #PrecisionMedicine
553 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.